180 Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,833
| Closed | -$238K | – | 448 |
|
|
2024
Q2 | $238K | Sell |
2,833
-60
| -2% | -$5.04K | 0.04% | 365 |
|
|
2024
Q1 | $253K | Sell |
2,893
-137
| -5% | -$12K | 0.05% | 330 |
|
|
2023
Q4 | $297K | Sell |
3,030
-187
| -6% | -$18.3K | 0.06% | 279 |
|
|
2023
Q3 | $285K | Buy |
3,217
+222
| +7% | +$19.6K | 0.06% | 271 |
|
|
2023
Q2 | $257K | Buy |
2,995
+98
| +3% | +$8.42K | 0.06% | 282 |
|
|
2023
Q1 | $282K | Buy |
+2,897
| New | +$282K | 0.07% | 273 |
|
|
2021
Q4 | – | Sell |
-5,450
| Closed | -$414K | – | 378 |
|
|
2021
Q3 | $414K | Buy |
5,450
+448
| +9% | +$34K | 0.09% | 216 |
|
|
2021
Q2 | $385K | Buy |
5,002
+1,157
| +30% | +$89.1K | 0.09% | 223 |
|
|
2021
Q1 | $300K | Buy |
+3,845
| New | +$300K | 0.07% | 249 |
|